Javascript must be enabled to continue!
Curcumin Ameliorates Paclitaxel-Induced Pain Hypersensitivity via Alleviation of Inflammation and Oxidative Stress in Rats
View through CrossRef
Painful peripheral neuropathy is the main dose-limiting and long lasting side-effect of paclitaxel therapy. Despite enormous research, there is no effective treatment for paclitaxel-induced peripheral neuropathic pain owing to poor understanding of pathophysiological mechanisms. Growing evidence indicates oxidative-nitrosative stress is one of the leading factors causing chemotherapy induced peripheral neuropathy. Recently, involvement of neuroinflammation has been suggested in the development of paclitaxel-induced neuropathic pain. It is postulated that abrogating cytokine release and improving antioxidant defenses might be suitable targets in controlling neuroinflammation and oxidative-nitrosative stress mediated nociceptive hypersensitivities. Therefore, the study evaluated the effect of curcumin on paclitaxel-induced neuropathic pain in rats. Peripheral neuropathy was induced by administration of paclitaxel (2 mg/kg per injection) intraperitoneally on four alternate days (days 0, 2, 4, 6). Thermal hyperalgesia and mechanical allodynia were assessed and the markers of inflammation and oxidative-nitrosative stress were estimated. Administration of curcumin (50 and 100 mg/kg, p.o.) for 2 weeks started 14 days after paclitaxel injection significantly alleviated paclitaxel-induced nociceptive behavioural hypersensitivity observed as reduced thermal hyperalgesia and mechanical allodynia. These observed ameliorative effects of curcumin on paclitaxel-induced neuropathic pain are accompanied by reduction of tumour necrosis factor-α, a pro-inflammatory cytokine, in both spinal cord and dorsal root ganglia and oxidative-nitrosative stress in spinal cord. The results of the present study demonstrated antihyperalgesic and antiallodynic effects of curcumin. Additional clinical studies are warranted to evaluate therapeutic potential of curcumin as antinociceptive agent in the treatment of paclitaxel-induced neuropathic pain.Â
Lapin Press Publications (LPP)
Title: Curcumin Ameliorates Paclitaxel-Induced Pain Hypersensitivity via Alleviation of Inflammation and Oxidative Stress in Rats
Description:
Painful peripheral neuropathy is the main dose-limiting and long lasting side-effect of paclitaxel therapy.
Despite enormous research, there is no effective treatment for paclitaxel-induced peripheral neuropathic pain owing to poor understanding of pathophysiological mechanisms.
Growing evidence indicates oxidative-nitrosative stress is one of the leading factors causing chemotherapy induced peripheral neuropathy.
Recently, involvement of neuroinflammation has been suggested in the development of paclitaxel-induced neuropathic pain.
It is postulated that abrogating cytokine release and improving antioxidant defenses might be suitable targets in controlling neuroinflammation and oxidative-nitrosative stress mediated nociceptive hypersensitivities.
Therefore, the study evaluated the effect of curcumin on paclitaxel-induced neuropathic pain in rats.
Peripheral neuropathy was induced by administration of paclitaxel (2 mg/kg per injection) intraperitoneally on four alternate days (days 0, 2, 4, 6).
Thermal hyperalgesia and mechanical allodynia were assessed and the markers of inflammation and oxidative-nitrosative stress were estimated.
Administration of curcumin (50 and 100 mg/kg, p.
o.
) for 2 weeks started 14 days after paclitaxel injection significantly alleviated paclitaxel-induced nociceptive behavioural hypersensitivity observed as reduced thermal hyperalgesia and mechanical allodynia.
These observed ameliorative effects of curcumin on paclitaxel-induced neuropathic pain are accompanied by reduction of tumour necrosis factor-α, a pro-inflammatory cytokine, in both spinal cord and dorsal root ganglia and oxidative-nitrosative stress in spinal cord.
The results of the present study demonstrated antihyperalgesic and antiallodynic effects of curcumin.
Additional clinical studies are warranted to evaluate therapeutic potential of curcumin as antinociceptive agent in the treatment of paclitaxel-induced neuropathic pain.
 .
Related Results
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Differential Diagnosis of Neurogenic Thoracic Outlet Syndrome: A Review
Abstract
Thoracic outlet syndrome (TOS) is a complex and often overlooked condition caused by the compression of neurovascular structures as they pass through the thoracic outlet. ...
Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel
Abstract B8: Caveolae-mediated endocytosis is critical for tumor cell response to nab-paclitaxel
Abstract
INTRODUCTION:
Pancreatic cancer is the fourth leading cause of cancer-related deaths in the United States and is typified by poor outcomes. G...
Abstract B14: A novel strategy for the treatment of melanoma
Abstract B14: A novel strategy for the treatment of melanoma
Abstract
Introduction: Approximately 76,000 individuals are diagnosed with melanoma, and about 9,000 die as a result of the disease each year in the United States. E...
Nghiên cứu bào chế curcumin dạng phytosome và dạng PEG hóa
Nghiên cứu bào chế curcumin dạng phytosome và dạng PEG hóa
Curcumin có nhiều tác dụng dược lý quan trọng nhưng chưa được ứng dụng nhiều trên lâm sàng do sinh khả dụng thấp. Phytosome curcumin và PEG-CUR được nghiên cứu để tăng sinh khả dụn...
A Short Review on the Efficacy of Derivatives of Curcumin
A Short Review on the Efficacy of Derivatives of Curcumin
Abstract:
Curcumin with medicinal value should possess good bioavailability and stability. Unfortunately,
the bioavailability of curcumin is less, and its stability depends on the ...
Dynamic long-term microstructural and ultrastructural alterations in sensory nerves of rats of paclitaxel-induced neuropathic pain
Dynamic long-term microstructural and ultrastructural alterations in sensory nerves of rats of paclitaxel-induced neuropathic pain
Background
Paclitaxel, as a first line anti-neoplastic compound, frequently produces long-term pain after tumors have been treated. Clinical manifestations are varied a...
Abstract 1071: Efficacy of targeted osmotic lysis using pulsed electric field stimulation compared to paclitaxel for treating murine, triple-negative breast carcinoma
Abstract 1071: Efficacy of targeted osmotic lysis using pulsed electric field stimulation compared to paclitaxel for treating murine, triple-negative breast carcinoma
Abstract
Targeted osmotic lysis (TOL), the concurrent stimulation of voltage-gated sodium channels (VGSCs) and blockade of Na+ pumps, kills up to 100% of highly mali...
Abstract 1849: Determining the molecular requirements for paclitaxel-induced spindle multipolarity
Abstract 1849: Determining the molecular requirements for paclitaxel-induced spindle multipolarity
Abstract
Paclitaxel (TaxolTM) and other microtubule poisons are standard chemotherapy agents used in the treatment of breast cancer. However, only a subset of patien...

